Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD

Jakk Wong, Yvette M Piceno, Todd Z DeSantis, Madeleine Pahl, Gary L Andersen, Nosratola D Vaziri, Jakk Wong, Yvette M Piceno, Todd Z DeSantis, Madeleine Pahl, Gary L Andersen, Nosratola D Vaziri

Abstract

Background: Intestinal microbiome constitutes a symbiotic ecosystem that is essential for health, and changes in its composition/function cause various illnesses. Biochemical milieu shapes the structure and function of the microbiome. Recently, we found marked differences in the abundance of numerous bacterial taxa between ESRD and healthy individuals. Influx of urea and uric acid and dietary restriction of fruits and vegetables to prevent hyperkalemia alter ESRD patients' intestinal milieu. We hypothesized that relative abundances of bacteria possessing urease, uricase, and p-cresol- and indole-producing enzymes is increased, while abundance of bacteria containing enzymes converting dietary fiber to short-chain fatty acids (SCFA) is reduced in ESRD.

Methods: Reference sets of bacteria containing genes of interest were compiled to family, and sets of intestinal bacterial families showing differential abundances between 12 healthy and 24 ESRD individuals enrolled in our original study were compiled. Overlap between sets was assessed using hypergeometric distribution tests.

Results: Among 19 microbial families that were dominant in ESRD patients, 12 possessed urease, 5 possessed uricase, and 4 possessed indole and p-cresol-forming enzymes. Among 4 microbial families that were diminished in ESRD patients, 2 possessed butyrate-forming enzymes. Probabilities of these overlapping distributions were <0.05.

Conclusions: ESRD patients exhibited significant expansion of bacterial families possessing urease, uricase, and indole and p-cresol forming enzymes, and contraction of families possessing butyrate-forming enzymes. Given the deleterious effects of indoxyl sulfate, p-cresol sulfate, and urea-derived ammonia, and beneficial actions of SCFA, these changes in intestinal microbial metabolism contribute to uremic toxicity and inflammation.

References

    1. Vaziri ND, Wong J, Pahl MV, et al. Chronic kidney disease alters the composition of intestinal microbial flora. Kidney Int. 2013;83:308–315.
    1. Lee YT. Urea concentration in intestinal fluids in normal and uremic dogs. J Surg Oncol. 1971;3:163–168.
    1. Swales JD, Tange JD, Evans DJ. Intestinal ammonia in uraemia: the effect of a urease inhibitor, acetohydroxamic acid. Clin Sci. 1972;42:105–112.
    1. Bourke E, Milne MD, Stokes GS. Caecal pH and ammonia in experimental uraemia. Gut. 1966;7:558–561.
    1. Kang JY. The gastrointestinal tract in uremia. Dig Dis Sci. 1993;38:257–268.
    1. Vaziri ND, Dure-Smith B, Miller R, Mirahmadi MK. Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases. For Peer Review Am J Gastroenterol. 1985;80:608–611.
    1. Vaziri ND, Freel RW, Hatch M. Effect of chronic experimental renal insufficiency on urate metabolism. J Am Soc Nephrol. 1995;6:1313–1317.
    1. Hatch M, Vaziri ND. Enhanced enteric excretion of urate in rats with chronic renal failure. Clin Sci. 1994;86:511–516.
    1. Hatch M, Freel RW, Vaziri ND. Intestinal excretion of oxalate in chronic renal failure. J Am Soc Nephrol. 1994;5:1339–1343.
    1. Aronov PA, Luo FJ, Plummer NS, et al. Colonic contribution to uremic solutes. J Am Soc Nephrol. 2011;22:1769–1776.
    1. Meinardi S, Jin KB, Barletta B, Blake DR, Vaziri ND. Exhaled breath and fecal volatile organic biomarkers of chronic kidney disease. Biochim Biophys Acta. 2013;1830:2531–2537.
    1. Niwa T. Uremic toxicity of indoxyl sulfate. Nagoya J Med Sci. 2010;72:1–11.
    1. Smith EA, Macfarlane GT. Formation of phenolic and indolic compounds by anaerobic bacteria in the human large intestine. Microb Ecol. 1997;33:180–188.
    1. Yokoyama MT, Carlson JR. Production of skatole and para-cresol by rumen Lactobacillus sp. Appl Environ Microbiol. 1981;41:71–76.
    1. Ward LA, Johnson KA, Robinson IM, Yokoyama MT. Isolation from swine feces of a bacterium which decarboxylates p-hydroxyphenylacetic acid to 4-methylphenol (p cresol). Appl Environ Microbiol. 1987;53:189–192.
    1. Selmer T, Andrei PI. p-Hydroxyphenylacetate decarboxylase from Clostridium difficile: A novel glycyl radical enzyme catalyzing the formation of p-cresol. Eur J Biochem. 2001;268:1363–1372.
    1. McDonald D, Price MN, Goodrich J, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012;6(3):610–618.
    1. Levett PN, Phillips KD. Gas chromatographic identification of Clostridium difficile and detection of cytotoxin from a modified selective medium. J Clin Pathol. 1985;38:82–85.
    1. Berg JD, Mills RG, Coleman DJ. Improved gas-liquid chromatography method for the identification of Clostridium difficile. J Clin Pathol. 1985;38:108–113.
    1. Dawson LF, Donahue EH, Cartman ST, et al. The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains. BMC Microbiol. 2011;11:86.
    1. Vaziri ND, Yuan J, Norris K. Role of Urea in Intestinal Barrier Dysfunction and Disruption of Epithelial Tight Junction in Chronic Kidney Disease. Am J Nephrol. 2013;37:1–6.
    1. Vaziri ND, Yuan J, Khazaeli M, Masuda Y, Ichii H, Liu S. Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption. Amer J Nephrol. 2013;37:518–525.
    1. Vaziri ND. CKD impairs barrier function and alters microbial flora of the intestine - A major link to inflammation and uremic toxicity. Curr Opin Nephrol Hyperten. 2012;21:587–592.
    1. Feroze U, Kalantar-Zadeh K, Sterling KA, et al. Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients. J Ren Nutr. 2012;22:317–326.
    1. Gonçalves S, Pecoits-Filho R, Perreto S, et al. Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrol Dial Transplant. 2006;21:2788–2794.
    1. Szeto CC, Kwan BC, Chow KM, et al. Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. For Peer Review Clin J Am Soc Nephrol. 2008;3:431–436.
    1. Cachofeiro V, Goicochea M, de Vinuesa SG, Oubiña P, Lahera V, Luño J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl. 2008;111:S4–9.
    1. Stenvinkel P. Inflammation in end-stage renal disease: the hidden enemy. Nephrology (Carlton) 2006;11:36–41.
    1. Ruiz S, Pergola PE, Zager RA, Vaziri ND. Targeting Nrf2 activation to ameliorate oxidative stress and inflammation in Chronic Kidney Disease. Kidney Int. 2013;83(6):1029–1041.
    1. Vaziri ND, Yuan J, Rahimi A, Ni Z, Said H, Subramanian VS. Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol Dial Transplant. 2012;27:2686–2693.
    1. Vaziri ND, Yuan J, Nazertehrani S, Ni Z, Liu S. Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction. Amer J Nephrol. 2013;38:99–103.
    1. Fierer N, Jackson RB. The diversity and biogeography of soil bacterial communities. Proc Natl Acad Sci. 2006;103:626–631.
    1. Wakelin SA, Macdonald LM, Rogers SL, Gregg AL, Bolger TP, Baldock JA. Habitat selective factors influencing the structural composition and functional capacity of microbial communities in agricultural soils. Soil Biol Biochem. 2008;40:803–813.
    1. Nacke H, Thurmer A, Wollherr A, et al. Pyrosequencing-based assessment of bacterial community structure along different management types in German forest and grassland soils. PLoS ONE. 2011;6(2):e17000. doi:10.1371/journal.pone.0017000.
    1. Brown CL, Hill MJ, Richards P. Bacterial ureases in uraemic men. Lancet. 1971;298(7721):406–408.
    1. Lee HJ, Pahl MV, Vaziri ND, Blake DR. Effect of hemodialysis and diet on the exhaled breath methanol concentration in patients with ESRD. J Ren Nutr. 2012;22:357–364.
    1. Donohoe DR, Garge N, Zhang X, et al. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 2011;13:517–526.
    1. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489:220–230.
    1. Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr. 2012;22:149–156.
    1. Hendrikx TK, van Gurp EA, Mol WM, et al. End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells. Nephrol Dial Transplant. 2009;24:1969–1978.
    1. Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341:569–573.
    1. Krishnamurthy VMR, Wei G, Baird BC, et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int. 2012;81:300–306.
    1. Niwa T. Phenol and p-cresol accumulated in uremic serum measured by HPLC with fluorescence detection. Clin Chem. 1993;39:108–111.
    1. Wikoff WR, Anfora AT, Liu J, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci. 2009;106:3698–3703.
    1. Smith EA, Macfarlane GT. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol. 1996;81:288–302.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa